I said earlier on this board Fresenius -pronounced (FRA-SIN-I-US)- German company has the contract option to replace up to 25% of their current USA locations with Affy's new drug. They are now in 100 locations as a test. They will add almost 400 more in the USA by January 2013.That will bring their USA total to about 525 locations. They have about 2100 centers in the USA. These numbers do not even consider their international locations.
My info is that all the clinics will eventually be using Omenty...Some local clinics are already using and some other local clinics have just recently received their first shipments. .Stock will be going up. I'm a little concerned about how much profit Affy will make seeing that it is in a partnership with a japanese pharmacutical company. 1/2 of profits will be split with them. But, I believe Affy is in great shape for a buy out by their partner in Japan or by another company. Just my opinion....."A little bird told me"..